The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.

MLA

Gonzalez-Fernandez, Ezekiel, et al. “The Adducin Saga: Pleiotropic Genomic Targets for Precision Medicine in Human Hypertension-Vascular, Renal, and Cognitive Diseases.” Physiological Genomics, vol. 54, no. 2, Feb. 2022, pp. 58–70. EBSCOhost, https://doi.org/10.1152/physiolgenomics.00119.2021.

APA

Gonzalez-Fernandez, E., Fan, L., Wang, S., Liu, Y., Gao, W., Thomas, K. N., Fan, F., & Roman, R. J. (2022). The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases. Physiological Genomics, 54(2), 58–70. https://doi.org/10.1152/physiolgenomics.00119.2021

Chicago

Gonzalez-Fernandez, Ezekiel, Letao Fan, Shaoxun Wang, Yedan Liu, Wenjun Gao, Kirby N Thomas, Fan Fan, and Richard J Roman. 2022. “The Adducin Saga: Pleiotropic Genomic Targets for Precision Medicine in Human Hypertension-Vascular, Renal, and Cognitive Diseases.” Physiological Genomics 54 (2): 58–70. doi:10.1152/physiolgenomics.00119.2021.